methotrexate has been researched along with Chondrocalcinosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ferraccioli, G; Gremese, E; Zanardi, R | 1 |
| Kakoullis, L; Papachristodoulou, E; Parperis, K; Rosenthal, AK | 1 |
| Blumhardt, S; Finckh, A; Guerne, PA; Kyburz, D; Madigan, A; Mc Carthy, GM; Neto, D; Rappoport, G; Van Linthoudt, D; Weber, M | 1 |
| Andrés, M; Pascual, E; Sivera, F | 3 |
| Rosenthal, AK; Ryan, LM | 1 |
| Distler, O; Franzen, D; Jungraithmayr, W; Kolios, AG; Tzafos, S; Weder, W | 1 |
| Bardin, T; Chevalier, X; Doan, TH; Forestier, R; Leparc, JM; Richette, P | 1 |
| Announ, N; Guerne, PA | 2 |
| Abhishek, A; Doherty, M | 1 |
| Chollet-Janin, A; Dudler, J; Finckh, A; Guerne, PA | 1 |
| Rothschild, B | 1 |
5 review(s) available for methotrexate and Chondrocalcinosis
| Article | Year |
|---|---|
Management of calcium pyrophosphate crystal deposition disease: A systematic review.
Topics: Aged; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Gout; Humans; Methotrexate; Randomized Controlled Trials as Topic | 2021 |
Current advances in therapies for calcium pyrophosphate crystal arthritis.
Topics: Antirheumatic Agents; Arthritis; Biological Products; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Glucocorticoids; Humans; Interleukin-1beta; Methotrexate | 2016 |
Calcium Pyrophosphate Deposition Disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage; Chondrocalcinosis; Crystallization; Diagnostic Errors; Glucocorticoids; Humans; Injections, Intra-Arterial; Methotrexate; Prevalence; Radiography; Risk Factors; Terminology as Topic | 2016 |
Treating difficult crystal pyrophosphate dihydrate deposition disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Glucocorticoids; Humans; Magnesium Compounds; Methotrexate; Probenecid; Uricosuric Agents | 2008 |
Pathophysiology of articular chondrocalcinosis--role of ANKH.
Topics: Animals; Ankylosis; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Humans; Hydroxychloroquine; Interleukin-1; Methotrexate; Mutation; Phosphate Transport Proteins; Risk Factors | 2011 |
1 trial(s) available for methotrexate and Chondrocalcinosis
| Article | Year |
|---|---|
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chondrocalcinosis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2014 |
8 other study(ies) available for methotrexate and Chondrocalcinosis
| Article | Year |
|---|---|
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Humans; Methotrexate; Naproxen; Neck Pain; Syndrome | 2023 |
Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
Topics: Arthritis; Calcium Pyrophosphate; Chondrocalcinosis; Chronic Disease; Female; Humans; Male; Methotrexate; Risk Assessment; Sampling Studies; Severity of Illness Index; Treatment Outcome | 2015 |
Rapid Growth of Lung Nodules due to Combined Pulmonary Vasculitis, Silicoanthracosis, and Chondrocalcinosis.
Topics: Anthracosilicosis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antirheumatic Agents; Arthritis; Chondrocalcinosis; Humans; Immunologic Factors; Lung; Male; Methotrexate; Middle Aged; Multiple Pulmonary Nodules; Rituximab; Thoracoscopy; Tomography, X-Ray Computed | 2016 |
Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al.
Topics: Antirheumatic Agents; Chondrocalcinosis; Humans; Methotrexate; Recurrence; Treatment Outcome | 2008 |
Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chondrocalcinosis; Chronic Disease; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2012 |
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chondrocalcinosis; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
Suppressive treatment of calcium pyrophosphate deposition disease.
Topics: Chondrocalcinosis; Humans; Immunosuppressive Agents; Methotrexate | 2007 |
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Disease Progression; Glucocorticoids; Gout Suppressants; Humans; Injections, Intra-Articular; Interleukin-1beta; Methotrexate; Middle Aged; Risk Factors; Synovial Membrane | 2007 |